Artelo Biosciences Financials
ARTLWDelisted Stock | USD 0.01 0.00 0.00% |
Artelo |
Understanding current and past Artelo Biosciences Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Artelo Biosciences' financial statements are interrelated, with each one affecting the others. For example, an increase in Artelo Biosciences' assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Artelo Biosciences' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Artelo Biosciences. Check Artelo Biosciences' Beneish M Score to see the likelihood of Artelo Biosciences' management manipulating its earnings.
Artelo Biosciences Stock Summary
Artelo Biosciences competes with Arrowhead Pharmaceuticals, Krystal Biotech, BioNTech, Moderna, and Ascletis Pharma. Artelo Biosciences, Inc., an ethical biopharmaceutical company, focuses on developing, licensing, and commercializing cannabinoid therapeutic treatments. Artelo Biosciences, Inc. was founded in 2011 and is based in La Jolla, California. Artelo Biosciences is traded on BATS Exchange in USA.Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
Business Address | 505 Lomas Santa |
Sector | Pharmaceuticals |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.artelobio.com |
Phone | 858 925 7049 |
Currency | USD - US Dollar |
Artelo Biosciences Key Financial Ratios
Artelo Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Artelo Biosciences's current stock value. Our valuation model uses many indicators to compare Artelo Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Artelo Biosciences competition to find correlations between indicators driving Artelo Biosciences's intrinsic value. More Info.Artelo Biosciences is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Artelo Biosciences by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Artelo Biosciences Market Pulse
Quote | 0.0056 |
Change(%) | 0.00 |
Change | 0.00 |
Open | 0.0056 |
Low | 0.0056 |
High | 0.0056 |
Volume | 0 |
Exchange | NASDAQ |
Steps to analyze company Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Artelo Biosciences is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Artelo has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Artelo Biosciences' financials are consistent with your investment objective using the following steps:- Review Artelo Biosciences' balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Artelo Biosciences' liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Artelo Biosciences' financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Artelo Biosciences' stock is overvalued or undervalued.
Artelo Biosciences November 26, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Artelo Biosciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Artelo Biosciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Artelo Biosciences based on widely used predictive technical indicators. In general, we focus on analyzing Artelo Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Artelo Biosciences's daily price indicators and compare them against related drivers.
Downside Deviation | 30.72 | |||
Information Ratio | 0.0817 | |||
Maximum Drawdown | 147.53 | |||
Value At Risk | (41.25) | |||
Potential Upside | 68.38 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Consideration for investing in Artelo Stock
If you are still planning to invest in Artelo Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Artelo Biosciences' history and understand the potential risks before investing.
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |